Explore Floy's AI Portfolio at ECR 2026

Floy®, the opportunistic screening AI provider, hosts an exclusive gin tasting daily from 3:30 PM. Discover distinctive gins and exchange ideas on AI-driven screening.

Photo: Explore Floys AI Portfolio at ECR 2026
Source: Floy

Floy® introduces the world’s first AI-powered detection of osteoporosis in routine MRI and CT scans of the spine. Fully integrated into daily workflows, it enables opportunistic bone density assessment with up to 93% specificity, supporting preventive action before fractures occur.  Visit Booth 251 in Hall X2 to explore the full AI portfolio and enjoy the exclusive daily gin tasting from 3:30 PM. Floy® will also present at the AI Theatre on March 6 at 2:10 PM: Rethinking Routine Imaging. The Case for Opportunistic AI Screening.

Supplier

Floy GmbH

Ludwigstraße 9
80539 München
Germany

www.floy.com

info@floy.com

related articles
popular articles